Reaction
Dandruff reporting signals
As of the last recalculation, Dandruff appears in 2,177 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is MINOXIDIL FOAM 5% (WOMENS) (PRR 174.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Minoxidil Foam 5% (Womens) | 472 | 174.4 | 176.9 |
| Minoxidil | 578 | 167.1 | 169.3 |
| Ketoconazole | 79 | 45.2 | 45.4 |
| Ketoconazole Foam | 49 | 32.4 | 32.5 |
| Ketoconazole Cream, 2% | 49 | 32.3 | 32.4 |
| Biotin | 31 | 9.6 | 9.6 |
| Finasteride | 52 | 8.4 | 8.4 |
| Clobetasol Propionate Ointment Usp, 0.05% | 7 | 6.5 | 6.5 |
| Clobetasol Propionate | 7 | 6.5 | 6.5 |
| Secukinumab | 97 | 6.0 | 6.0 |
| Risankizumab-Rzaa | 39 | 4.6 | 4.6 |
| Desoximetasone | 9 | 4.5 | 4.5 |
| Panitumumab | 7 | 4.3 | 4.3 |
| Apalutamide | 5 | 4.1 | 4.1 |
| Bimekizumab | 8 | 3.6 | 3.6 |
| Dupilumab | 141 | 2.9 | 2.9 |
| Apremilast | 35 | 2.3 | 2.3 |
| Salicylic Acid | 3 | 0.5 | 0.5 |
| Adapalene | 5 | 0.3 | 0.3 |